[go: up one dir, main page]

PE20110845A1 - Nuevos compuestos heterociclicos nitrogenados, preparacion de los mismos y utilizacion de los mismos como medicamentos antibacterianos - Google Patents

Nuevos compuestos heterociclicos nitrogenados, preparacion de los mismos y utilizacion de los mismos como medicamentos antibacterianos

Info

Publication number
PE20110845A1
PE20110845A1 PE2011000827A PE2011000827A PE20110845A1 PE 20110845 A1 PE20110845 A1 PE 20110845A1 PE 2011000827 A PE2011000827 A PE 2011000827A PE 2011000827 A PE2011000827 A PE 2011000827A PE 20110845 A1 PE20110845 A1 PE 20110845A1
Authority
PE
Peru
Prior art keywords
same
nitrogenated
preparation
new
antibacterial drugs
Prior art date
Application number
PE2011000827A
Other languages
English (en)
Inventor
Maxime Lampilas
David Alun Rowlans
Marie-Edith Gourdel
Emilie Renaud
Camille Pierres
Adel Kebsi
Benoît Ledoussal
Original Assignee
Novexel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40548019&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20110845(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novexel filed Critical Novexel
Publication of PE20110845A1 publication Critical patent/PE20110845A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

SE REFIERE A UN COMPUESTO DE FORMULA (I) DONDE: R1 ES UN RADICAL (CH2)n-NH2 SIENDO n DE 1-2; R2 ES H; R3 Y R4 FORMAN UN RADICAL PIRAZOLILO SUSTITUIDO POR UN GRUPO (CH2)m-(C(O))p-R5 SIENDO m DE 0-3, p ES 0-1 Y R5 ES HIDROXI. SON COMPUESTOS PREFERIDOS: TRANS 8-(AMINOMETIL)-2-CARBAMOIL-4,8-DIHIDRO-5-(SULFOOXI)-4,7-METANO-7H-PIRAZOLO[3,4-E][1,3] DIACEPIN-6-(5H)-ONA; TRANS 8-(AMINOMETIL)-5,6-DIHIDRO-6-OXO-5-(SULFOOXI)-4H-4,7-METANOPIRAZOLO[3,4-e][1,3]DIACEPIN-2(8H)-ACETAMIDA; ENTRE OTROS. DICHOS COMPUESTOS SON HETEROCICLICOS NITROGENADOS UTILES COMO ANTIBACTERIANOS
PE2011000827A 2008-10-03 2009-08-03 Nuevos compuestos heterociclicos nitrogenados, preparacion de los mismos y utilizacion de los mismos como medicamentos antibacterianos PE20110845A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0805472A FR2936798B1 (fr) 2008-10-03 2008-10-03 Nouveaux composes heterocycliques azotes, leur preparation et leur utilisation comme medicaments antibacteriens.

Publications (1)

Publication Number Publication Date
PE20110845A1 true PE20110845A1 (es) 2011-11-17

Family

ID=40548019

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2011000827A PE20110845A1 (es) 2008-10-03 2009-08-03 Nuevos compuestos heterociclicos nitrogenados, preparacion de los mismos y utilizacion de los mismos como medicamentos antibacterianos

Country Status (18)

Country Link
US (1) US8067435B2 (es)
EP (2) EP2344499A1 (es)
JP (1) JP5555240B2 (es)
KR (1) KR20110067137A (es)
CN (1) CN102203094B (es)
AU (1) AU2009299511A1 (es)
BR (1) BRPI0919810A8 (es)
CA (1) CA2739503A1 (es)
CL (1) CL2011000729A1 (es)
CO (1) CO6361957A2 (es)
EA (1) EA021799B1 (es)
EC (1) ECSP11010946A (es)
FR (1) FR2936798B1 (es)
IL (1) IL212059A0 (es)
MX (1) MX2011003573A (es)
PE (1) PE20110845A1 (es)
WO (1) WO2010038115A1 (es)
ZA (1) ZA201102429B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8772490B2 (en) 2010-12-22 2014-07-08 Meiji Seika Pharma Co., Ltd. Optically active diazabicyclooctane derivatives and process for preparing the same
PT2872510T (pt) 2011-08-30 2017-03-01 Wockhardt Ltd Derivados de 1,6-diazabiciclo[3,2,1]octan-7-ona e seu uso no tratamento de infeções bacterianas
AU2012310136B2 (en) * 2011-09-13 2016-07-07 Wockhardt Limited Nitrogen containing compounds and their use
JP2015512419A (ja) * 2012-03-30 2015-04-27 キュービスト ファーマシューティカルズ， インコーポレイテッド イソオキザゾールβ−ラクタマーゼ阻害剤
AR090539A1 (es) * 2012-04-02 2014-11-19 Astrazeneca Ab COMPUESTOS INHIBIDORES DE b LACTAMASA
EP2857401B8 (en) 2012-05-30 2019-11-20 Meiji Seika Pharma Co., Ltd. NOVEL ß-LACTAMASE INHIBITOR AND METHOD FOR PRODUCING SAME
KR101946107B1 (ko) 2012-08-25 2019-02-08 욱크하르트 리미티드 １,６-디아자비시클로〔３,２,１〕옥탄-７-온 유도체 및 세균 감염의 치료에서의 이의 용도
US10000491B2 (en) 2013-09-24 2018-06-19 Meiji Seika Pharma Co., Ltd. Process for producing diazabicyclooctane derivative and intermediate thereof
NZ719568A (en) 2013-10-08 2018-06-29 Meiji Seika Pharma Co Ltd Crystals of diazabicyclooctane derivative and production method for crystals of diazabicyclooctane derivative
EP3055311B1 (en) * 2013-10-11 2017-08-09 Wockhardt Limited Nitrogen containing compounds and their use
AU2015350128B2 (en) 2014-11-17 2019-05-16 Entasis Therapeutics Limited Combination therapy for treatment of resistant bacterial infections
AU2015355970B2 (en) 2014-12-05 2020-05-21 Meiji Seika Pharma Co., Ltd. Method for producing crystals of diazabicyclooctane derivative and stable lyophilized preparation
AU2016239209A1 (en) 2015-03-31 2017-10-12 Mutabilis Novel heterocyclic compounds and their use in preventing or treating bacterial infections
EP3075733A1 (en) * 2015-03-31 2016-10-05 Mutabilis Novel heterocyclic compounds and their use in preventing or treating bacterial infections
AU2016239861A1 (en) * 2015-04-03 2017-10-12 Mutabilis Heterocyclic compounds and their use in preventing or treating bacterial infections
HK1254550A1 (zh) 2015-10-02 2019-07-19 乐高化学生物科学股份有限公司 用於抑制β-内酰胺酶的组合物和方法
CN114591223B (zh) 2016-09-16 2025-01-24 恩塔西斯治疗有限公司 β-内酰胺酶抑制剂化合物
HUE057592T2 (hu) 2017-05-08 2022-05-28 Entasis Therapeutics Inc Vegyületek és eljárások bakteriális fertõzések kezelésére
EP3604315A1 (en) * 2018-07-30 2020-02-05 Mutabilis Heterocyclic compounds and their use in preventing or treating bacterial infections
CN119998293A (zh) * 2023-08-08 2025-05-13 成都四面体药物研究有限公司 一种含脲三环的β-内酰胺酶抑制剂、其制备方法及其用途

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL135036A0 (en) * 1997-09-15 2001-05-20 Procter & Gamble Antimicrobial quinolones, their compositions and uses
US6387928B1 (en) * 1997-09-15 2002-05-14 The Procter & Gamble Co. Antimicrobial quinolones, their compositions and uses
FR2812635B1 (fr) * 2000-08-01 2002-10-11 Aventis Pharma Sa Nouveaux composes heterocycliques, preparation et utilisation comme medicaments notamment comme anti- bacteriens
BR0116205A (pt) * 2000-12-14 2003-12-23 Procter & Gamble 2-piridonas antimicrobianas, suas composições e usos
EP1341781B1 (en) * 2000-12-14 2005-09-14 The Procter & Gamble Company Antimicrobial quinolones
FR2825705B1 (fr) * 2001-06-08 2005-05-20 Aventis Pharma Sa Nouveaux composes heterocycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacteriens
FR2833596B1 (fr) * 2001-12-14 2005-02-18 Aventis Pharma Sa Procede de preparation de derives d'echinocandine
FR2835186B1 (fr) * 2002-01-28 2006-10-20 Aventis Pharma Sa Nouveaux composes heterocycliques, actifs comme inhibiteurs de beta-lactamases
US6900224B2 (en) * 2002-07-31 2005-05-31 The Procter & Gamble Company Antimicrobial quinolones, their compositions and uses
FR2844273B1 (fr) 2002-09-05 2008-04-04 Aventis Pharma Sa Nouveaux composes heterocycliques, procede et intermediaires de preparation et utilisation comme medicament, notamment comme inhibiteurs de beta-lactamases et anti-bacteriens.
FR2844268B1 (fr) * 2002-09-11 2004-10-22 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, leurs procedes et intermediaires de preparation et les compositions qui les contiennent
FR2844270B1 (fr) * 2002-09-11 2006-05-19 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, leur procede et intermediaires de preparation et les compositions qui les contiennent
US7439253B2 (en) * 2002-12-06 2008-10-21 Novexel Heterocyclic compounds, their preparation and their use as medicaments, in particular as antibacterials and beta-lactamase inhibitors
FR2848210B1 (fr) * 2002-12-06 2007-10-19 Aventis Pharma Sa Nouveaux composes heterocycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacteriens et inhibiteurs de beta-lactamases
US7232833B2 (en) * 2003-03-28 2007-06-19 Novexel 4-substituted quinoline derivatives, method and intermediates for their preparation and pharmaceutical compositions containing them
US7449481B2 (en) * 2004-04-13 2008-11-11 Cephalon, Inc. Thio-substituted biaryl-methanesulfinyl derivatives
FR2914923B1 (fr) * 2007-04-12 2013-06-14 Novexel Nouveaux composes heterocycliques azotes,leur preparation et leur utilisation comme medicaments antibacteriens.
FR2937034B1 (fr) * 2008-10-10 2012-11-23 Novexel Nouveaux composes heterocycliques azotes, leur preparation et leur utilisation comme medicaments antibacteriens

Also Published As

Publication number Publication date
EP2845855A1 (fr) 2015-03-11
IL212059A0 (en) 2011-06-30
WO2010038115A1 (fr) 2010-04-08
CO6361957A2 (es) 2012-01-20
KR20110067137A (ko) 2011-06-21
CN102203094A (zh) 2011-09-28
ECSP11010946A (es) 2011-05-31
BRPI0919810A2 (pt) 2017-10-31
CL2011000729A1 (es) 2012-07-06
FR2936798A1 (fr) 2010-04-09
CA2739503A1 (fr) 2010-04-08
CN102203094B (zh) 2014-04-02
JP2012504593A (ja) 2012-02-23
ZA201102429B (en) 2012-05-30
US8067435B2 (en) 2011-11-29
BRPI0919810A8 (pt) 2017-12-12
FR2936798B1 (fr) 2012-09-28
AU2009299511A1 (en) 2010-04-08
MX2011003573A (es) 2011-08-12
EA201170522A1 (ru) 2011-12-30
JP5555240B2 (ja) 2014-07-23
US20100087648A1 (en) 2010-04-08
EP2344499A1 (fr) 2011-07-20
EA021799B1 (ru) 2015-09-30

Similar Documents

Publication Publication Date Title
PE20110845A1 (es) Nuevos compuestos heterociclicos nitrogenados, preparacion de los mismos y utilizacion de los mismos como medicamentos antibacterianos
AR082985A1 (es) INHIBIDORES DE PI3K-d Y METODOS DE SU USO Y PREPARACION
TN2009000199A1 (en) Heteromonocyclic compound and use thereof
HRP20090235A2 (hr) Karbonilirani (aza) cikloheksani kao ligandi dopaminskog receptora d<sub>3</sub>
MX343264B (es) Ciertas amino-piridazinas, composiciones de las mismas y metodos de uso de los mismos.
DE602006006850D1 (de) Als modulatoren von dopamin-d3-rezeptoren geeignete azabicyclo-(3,1,0)-hexan-derivate
AR054560A1 (es) Espiropiperidina como inhibidores de beta-secretasa para el tratamiento de la enfermedad de alzheimer
PH12012501363A1 (en) Benzazepine derivatives useful as vasopressin antagonists
CL2011002837A1 (es) Compuestos derivados de 1,2,4-triazolo[4,3-a]piridina, moduladores alostericos positivos de receptores mglur2; composicion farmaceutica; proceso para prepararla; y su uso en el tratamiento o la prevencion de un trastorno del sistema nervioso central tal como la ansiedad, esquizofrenia y migraña, entre otros.
ECSP099338A (es) Derivados de quiniclidina de ácido (hetero) arilcicloheptano carboxíclico como antagonistas del receptor muscarínico
ECSP099394A (es) Derivados de quinuclidinol como antogonistas de receptores muscarínicos
EA201592252A1 (ru) 6,7-ДИГИДРОПИРАЗОЛО[1,5-a]ПИРАЗИН-4(5H)-ОНОВЫЕ СОЕДИНЕНИЯ И ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ ОТРИЦАТЕЛЬНЫХ АЛЛОСТЕРИЧЕСКИХ МОДУЛЯТОРОВ РЕЦЕПТОРОВ MGLUR2
CO6210701A2 (es) Derivados de amidas del acido 6,7-dihidro-5h-imidazo[1,2-a]imidazol-3-carboxilico
PE20141553A1 (es) Compuestos de triazolopiridina como inhibidores de la ped10a
PE20211769A1 (es) Compuestos heteroaromaticos como inhibidores de vanina
AR067648A1 (es) Derivados de 2-aza-biciclo [2,2,2]octano, uso de los mismos y composiciones farmaceuticas que los contienen
MX2016005993A (es) Anfifilos biscationicos y triscationicos como agentes antimicrobianos.
CL2017002059A1 (es) Compuestos 4- sustitutos de benzoxaborol y uso de los mismos
NZ719465A (en) Quinoline derivatives as bromodomain inhibitors
PE20140239A1 (es) Derivados de 1,4-oxazepano
PE20091552A1 (es) Farmacoforos duales - antagonistas muscarinicos de pde4
UY30740A1 (es) Nuevo procedimiento para la preparacion de 4,4??-( 1-metil-1,2-etandilil)-bis-(2,6-piperazindiona)
AR073741A1 (es) Derivados heterociclicos de hidantoina, composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento de enfermedades inflamatorias, tales como psoriasis o artritis
IN2012DN03343A (es)
CO2022004391A2 (es) Derivados de 5-oxa-2–azaespiro[3.4]octano como agonistas de m4

Legal Events

Date Code Title Description
FD Application declared void or lapsed